Joseph P. Balint

Corporate Officer/Principal at Etubics Corp.

Health Technology

Consumer Services

Profile

Joseph P.
Balint is currently the Laboratory Director at Etubics Corp.
Previously, he worked at Cypress Bioscience, Inc. from 1982 to 1996, where he held the position of Director-Extracorporeal Products in 1989.
He obtained a doctorate degree from Rutgers State University of New Jersey.

Joseph P. Balint active positions

Companies	Position	Start
Etubics Corp. Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA.	Corporate Officer/Principal	-

All active positions of Joseph P. Balint

Former positions of Joseph P. Balint

Companies	Position	End
Cypress Bioscience, Inc. Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA.	Corporate Officer/Principal	31/12/1988

See the detail of Joseph P. Balint's experience

Training of Joseph P. Balint

Rutgers State University of New Jersey

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph P. Balint's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Etubics Corp. Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA.	Health Technology
Cypress Bioscience, Inc. Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA.	Health Technology